Although the expression of H19 SNPs and their correlations to clinical outcomes of bladder cancer are inconsistent among different ethnicities [6,7,25], the H19 polymorphic variants rs217727 and rs2107425 are certainly involved in UCC progression and bladder cancer regulation and may be applied as a predictor or therapeutic target for UCC. The gene discussed is H19; the disease is urinary bladder carcinoma.